Supernus Pharmaceuticals Inc (SUPN)
29.31
-0.95
(-3.14%)
USD |
NASDAQ |
Apr 25, 16:00
29.31
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals 1 Year Total Returns (Daily): -21.63% for April 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 25, 2024 | -21.63% |
April 24, 2024 | -19.76% |
April 23, 2024 | -22.67% |
April 22, 2024 | -23.29% |
April 19, 2024 | -21.01% |
April 18, 2024 | -20.42% |
April 17, 2024 | -21.09% |
April 16, 2024 | -18.39% |
April 15, 2024 | -16.83% |
April 12, 2024 | -16.99% |
April 11, 2024 | -13.11% |
April 10, 2024 | -14.73% |
April 09, 2024 | -14.45% |
April 08, 2024 | -15.26% |
April 05, 2024 | -6.47% |
April 04, 2024 | -6.92% |
April 03, 2024 | -7.08% |
April 02, 2024 | -8.45% |
April 01, 2024 | -7.48% |
March 28, 2024 | -6.27% |
March 27, 2024 | -7.31% |
March 26, 2024 | -9.20% |
March 25, 2024 | -8.44% |
March 22, 2024 | -2.38% |
March 21, 2024 | -4.17% |
Date | Value |
---|---|
March 20, 2024 | -1.97% |
March 19, 2024 | 0.63% |
March 18, 2024 | -2.12% |
March 15, 2024 | -7.12% |
March 14, 2024 | -8.22% |
March 13, 2024 | -0.94% |
March 12, 2024 | -5.86% |
March 11, 2024 | -7.26% |
March 08, 2024 | -17.65% |
March 07, 2024 | -19.68% |
March 06, 2024 | -18.94% |
March 05, 2024 | -23.74% |
March 04, 2024 | -23.04% |
March 01, 2024 | -20.99% |
February 29, 2024 | -20.99% |
February 28, 2024 | -17.32% |
February 27, 2024 | -19.15% |
February 26, 2024 | -22.37% |
February 23, 2024 | -24.72% |
February 22, 2024 | -27.57% |
February 21, 2024 | -27.51% |
February 20, 2024 | -28.63% |
February 16, 2024 | -26.47% |
February 15, 2024 | -25.67% |
February 14, 2024 | -28.56% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-62.34%
Minimum
Mar 18 2020
81.11%
Maximum
Mar 17 2021
-2.66%
Average
-3.54%
Median
Nov 09 2022
1 Year Total Returns (Daily) Benchmarks
Dynavax Technologies Corp | 4.10% |
Ligand Pharmaceuticals Inc | -7.76% |
Pacira BioSciences Inc | -42.53% |
Esperion Therapeutics Inc | 65.83% |
Collegium Pharmaceutical Inc | 57.33% |